Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Amplia Therapeutics Ltd. (INNMF) had Return on Tangible Equity of -24.44% for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$3.63M |
|
$-5.10M |
|
-- |
|
$3.63M |
|
$8.72M |
|
$-5.09M |
|
$-0.01M |
|
$-5.10M |
|
$-5.10M |
|
$-5.10M |
|
$-5.10M |
|
$-5.10M |
|
$-5.10M |
|
$-5.09M |
|
$-5.03M |
|
469.65M |
|
469.65M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$21.86M |
|
$0.02M |
|
$5.56M |
|
$27.42M |
|
$1.11M |
|
$0.17M |
|
$0.20M |
|
$1.30M |
|
$26.11M |
|
$20.86M |
|
$26.11M |
|
513.07M |
|
| Cash Flow Statement Financials | |
$-5.78M |
|
$-0.06M |
|
$17.16M |
|
$7.19M |
|
$18.43M |
|
$11.24M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.78 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
100.00% |
|
-140.09% |
|
-140.09% |
|
-138.41% |
|
-140.40% |
|
-140.40% |
|
$-5.80M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
-- |
|
1.15 |
|
317.72 |
|
-19.53% |
|
|
Return on Tangible Equity |
-24.44% |
-18.60% |
|
-19.40% |
|
$0.05 |
|
$-0.01 |
|
$-0.01 |
|